Literature DB >> 26026172

Analysis of asthma patients for cryptococcal seroreactivity in an urban German area.

Andreas Grahnert1, Uwe Müller1, Heiner von Buttlar1, Regina Treudler2, Gottfried Alber3.   

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that causes lung inflammation and meningoencephalitis in immunocompromised patients but is also able to asymptomatically infect immunocompetent individuals. C. neoformans is found ubiquitously especially in urban areas where it is spread by pigeons, and fungal exposure may predispose for asthma development already at an early age, as soon as confronted with pigeon droppings. In the study presented here, we investigated the presence of specific immunoglobulin G (IgG) against C. neoformans in sera from patients suffering from asthma in comparison to a healthy control cohort, accrued from the Leipzig Research Centre for Civilization Diseases (LIFE). For serological analysis we developed a flow cytometry (FACS) based assay specific for an acapsular strain of C. neoformans to comprehensively analyze different cryptococcal serotypes. Compared with the non-asthmatic cohort, asthmatics exhibited, as expected, an elevated level of total serum immunoglobulin E (IgE), whereas the IgG seroreactivity against C. neoformans was not significantly different among the two groups (P = .118). Nevertheless, there was a trend toward increased Cryptococcus-specific IgG antibodies in the serum of asthmatics. Additionally, in male asthmatics an increased IgG-mediated seroreactivity compared to female asthmatics was found. This points to a higher prevalence of subclinical C. neoformans infection in male asthmatics and may support the hypothesis of C. neoformans as a risk factor for the development of asthma in urban areas.
© The Author 2015. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cryptococcus neoformans; asthma; fungal allergy; seroreactivity

Mesh:

Substances:

Year:  2015        PMID: 26026172     DOI: 10.1093/mmy/myv024

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  5 in total

1.  Cryptococcus neoformans in Association with Dermatophagoides pteronyssinus has Pro- (IL-6/STAT3 Overproduction) and Anti-inflammatory (CCL2/ERK1/2 Downregulation) Effects on Human Bronchial Epithelial Cells.

Authors:  Henrique Ismarsi Souza; Aline Beatriz Mahler Pereira; Jhony Robison Oliveira; Paulo Roberto Silva; David Nascimento Silva Teixeira; Mario Leon Silva-Vergara; Alexandre Paula Rogério
Journal:  Inflammation       Date:  2022-01-11       Impact factor: 4.092

Review 2.  A titanic drug resistance threat in Cryptococcus neoformans.

Authors:  Hanna Zafar; Sophie Altamirano; Elizabeth R Ballou; Kirsten Nielsen
Journal:  Curr Opin Microbiol       Date:  2019-11-22       Impact factor: 7.934

3.  Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection.

Authors:  Carolina Firacative; A Elisabeth Gressler; Kristin Schubert; Bianca Schulze; Uwe Müller; Frank Brombacher; Martin von Bergen; Gottfried Alber
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

Review 4.  Mechanisms of Cryptococcus neoformans-Mediated Host Damage.

Authors:  Arturo Casadevall; Carolina Coelho; Alexandre Alanio
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

5.  Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.

Authors:  A Elisabeth Gressler; Daniela Volke; Carolina Firacative; Christiane L Schnabel; Uwe Müller; Andor Krizsan; Bianca Schulze-Richter; Matthias Brock; Frank Brombacher; Patricia Escandón; Ralf Hoffmann; Gottfried Alber
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.